Loading organizations...
Founded in 2018 by Achal Patel and Russell Gong, Cabinet Health is a Washington, District of Columbia based healthcare company developing over the counter and prescription medicines in sustainable, plastic free packaging. The firm utilizes a refillable glass bottle system paired with compostable pill packages to address the generation of over 190 billion single use plastic medicine bottles annually. Operating through direct to consumer ecommerce channels and business to business enterprise contracts, the company serves four Fortune 10 companies and maintains a headcount of six to twenty employees. Cabinet Health has secured thirteen patents for its proprietary packaging technology and generated over 27 million dollars in cumulative revenue. The enterprise has raised over 23 million dollars in total funding from venture capital investors like TechStars, SOGAL Ventures, Gaingels, Pixel Perfect Ventures, and Global Impact Fund.
Cabinet Health has raised $6.0M across 2 funding rounds.
Cabinet Health has raised $6.0M in total across 2 funding rounds.
Cabinet Health has raised $6.0M across 2 funding rounds. Most recently, it raised $4.0M Seed in February 2021.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Feb 1, 2021 | $4M Seed | — | Alumni Ventures, Canaan Partners, Jenny Fielding, Scott Hartley, Kleiner Perkins, Trace Cohen, NextGen Venture Partners, RED Swan Ventures, Rubicon VC, What IF Ventures | Announced |
| Jan 1, 2020 | $2M Seed | — | Alumni Ventures, Canaan Partners, Coughdrop Capital, Earl Grey Capital, Jenny Fielding, Scott Hartley, Keshif Ventures, Kleiner Perkins, Trace Cohen, NextGen Venture Partners, RED Swan Ventures, Rubicon VC, Techstars, Vibe Capital, What IF Ventures | Announced |
Cabinet Health is a direct-to-consumer healthcare company that develops and manufactures over-the-counter (OTC) and prescription medications in sustainable, refillable packaging to eliminate single-use plastics while ensuring higher quality and personalized care.[1][2][3] It serves consumers seeking eco-friendly alternatives, retail partners like CVS and Target, and enterprises including Fortune 10 customers and pharma distributors like McKesson, addressing the problems of pharmaceutical plastic waste (194 billion bottles produced yearly with only 3-7% recycled), frequent drug recalls (about 100 high-risk annually in the US), and low-quality OTC products through third-party batch-level testing for allergens, carcinogens, gluten, and purity.[1][2][3][4] The company has demonstrated strong growth momentum, generating $27.7M in cumulative revenue on $6.6M raised initially and scaling to $80M on $15M invested, with expansions into 711 CVS stores, 500 Target stores, Amazon, Grove, and enterprise contracts.[1][2][4]
Cabinet Health was founded in 2018 by Achal Patel and Russ Gong, who identified the need for sustainability in healthcare after over a decade collaborating on sustainable products and mission-driven brands in developing countries.[3][4] Patel brings deep supply chain expertise from 55 years of family manufacturing experience in India (FDA-audited facilities), while Gong, a US Army veteran, specializes in sustainable product development.[1][3] The idea emerged from their work abroad, leading to a focus on ditching plastic pill bottles; early traction included filing 13-14 patents for refillable systems, B-Corp certification, Shark Tank Season 14 appearance, and Fast Company’s Most Innovative Companies recognition in 2022.[1][2][3][4] Pivotal moments include launching national retail partnerships (e.g., CVS in 2023, Target in 2024), a pill bottle recycling program, and prescription refill services.[2][4]
Cabinet Health rides the sustainability wave in healthcare, targeting the massive plastic waste from 194 billion annual medicine bottles amid rising consumer demand for eco-products (80% of OTC buys in retail) and regulatory pressures on pharma packaging.[1][2][4] Timing aligns with post-2020 green initiatives, B-Corp trends, and e-commerce health booms, enabling rapid scaling from DTC to national retail (CVS, Target) and enterprise (Fortune 10, McKesson).[2][4] Market forces like frequent US drug recalls (5 daily) favor its quality testing, while its IP-protected supply chain accelerates transitions for big pharma, influencing the ecosystem by proving sustainable packaging viable at scale and inspiring competitors.[1][3]
Cabinet Health is poised for explosive growth through retail expansion (e.g., more national chains post-2023/2024 launches), prescription/telehealth rollout, and enterprise private-label deals, leveraging its $80M revenue track record and patents to capture share in the $100B+ OTC/RX market.[1][2][4] Trends like stricter ESG mandates, circular economy pushes, and AI-driven personalization in health platforms will amplify its edge, potentially evolving it into a full sustainable pharma platform influencing industry standards. As the pioneer ditching plastic for planet-friendly care, Cabinet exemplifies how mission-driven innovation delivers profitability and impact.
Cabinet Health has raised $6.0M in total across 2 funding rounds.
Cabinet Health's investors include Alumni Ventures, Canaan Partners, Jenny Fielding, Scott Hartley, Kleiner Perkins, Trace Cohen, NextGen Venture Partners, Red Swan Ventures, Rubicon VC, What If Ventures, Coughdrop Capital, Earl Grey Capital.
